OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The bad seed: Cancer stem cells in tumor development and resistance
Elle Koren, Yaron Fuchs
Drug Resistance Updates (2016) Vol. 28, pp. 1-12
Closed Access | Times Cited: 103
Elle Koren, Yaron Fuchs
Drug Resistance Updates (2016) Vol. 28, pp. 1-12
Closed Access | Times Cited: 103
Showing 26-50 of 103 citing articles:
Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 34
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 34
Terminally Exhausted CD8+ T Cells Resistant to PD-1 Blockade Promote Generation and Maintenance of Aggressive Cancer Stem Cells
Mohona Chakravarti, Sukanya Dhar, Saurav Bera, et al.
Cancer Research (2023) Vol. 83, Iss. 11, pp. 1815-1833
Open Access | Times Cited: 15
Mohona Chakravarti, Sukanya Dhar, Saurav Bera, et al.
Cancer Research (2023) Vol. 83, Iss. 11, pp. 1815-1833
Open Access | Times Cited: 15
p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act
Yuanfang Guo, Yufeng Tang, Guangping Lu, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2259-2259
Open Access | Times Cited: 14
Yuanfang Guo, Yufeng Tang, Guangping Lu, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2259-2259
Open Access | Times Cited: 14
Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells
Queenie Fernandes, Lubna Therachiyil, Abdul Quaiyoom Khan, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 191, pp. 106586-106586
Open Access | Times Cited: 14
Queenie Fernandes, Lubna Therachiyil, Abdul Quaiyoom Khan, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 191, pp. 106586-106586
Open Access | Times Cited: 14
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter
Roberto Ruiu, Valeria Rolih, Elisabetta Bolli, et al.
Cancer Immunology Immunotherapy (2018) Vol. 68, Iss. 1, pp. 131-141
Open Access | Times Cited: 45
Roberto Ruiu, Valeria Rolih, Elisabetta Bolli, et al.
Cancer Immunology Immunotherapy (2018) Vol. 68, Iss. 1, pp. 131-141
Open Access | Times Cited: 45
RETRACTED: KYA1797K down-regulates PD-L1 in colon cancer stem cells to block immune evasion by suppressing the β-catenin/STT3 signaling pathway
Zhiyan Ruan, Minhua Liang, Manxiang Lai, et al.
International Immunopharmacology (2019) Vol. 78, pp. 106003-106003
Closed Access | Times Cited: 42
Zhiyan Ruan, Minhua Liang, Manxiang Lai, et al.
International Immunopharmacology (2019) Vol. 78, pp. 106003-106003
Closed Access | Times Cited: 42
CTCs 2020: Great Expectations or Unreasonable Dreams
Elisabetta Rossi, Francesco� Fabbri
Cells (2019) Vol. 8, Iss. 9, pp. 989-989
Open Access | Times Cited: 36
Elisabetta Rossi, Francesco� Fabbri
Cells (2019) Vol. 8, Iss. 9, pp. 989-989
Open Access | Times Cited: 36
A CD44-targeted Cu(ii ) delivery 2D nanoplatform for sensitized disulfiram chemotherapy to triple-negative breast cancer
Zhiguo Gao, Yao‐Jia Li, Yu Zhang, et al.
Nanoscale (2020) Vol. 12, Iss. 15, pp. 8139-8146
Closed Access | Times Cited: 33
Zhiguo Gao, Yao‐Jia Li, Yu Zhang, et al.
Nanoscale (2020) Vol. 12, Iss. 15, pp. 8139-8146
Closed Access | Times Cited: 33
PIK3C3 regulates the expansion of liver CSCs and PIK3C3 inhibition counteracts liver cancer stem cell activity induced by PI3K inhibitor
F.C. Liu, Xiaoling Wu, Yanzhi Qian, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 6
Open Access | Times Cited: 33
F.C. Liu, Xiaoling Wu, Yanzhi Qian, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 6
Open Access | Times Cited: 33
The role of CD133 in hepatocellular carcinoma
Fengchao Liu, Yanzhi Qian
Cancer Biology & Therapy (2021) Vol. 22, Iss. 4, pp. 291-300
Open Access | Times Cited: 31
Fengchao Liu, Yanzhi Qian
Cancer Biology & Therapy (2021) Vol. 22, Iss. 4, pp. 291-300
Open Access | Times Cited: 31
Mitochondrial Fuel Dependence on Glutamine Drives Chemo-Resistance in the Cancer Stem Cells of Hepatocellular Carcinoma
Alan Chun Kit Lee, Pui Man Lau, Yiu Wa Kwan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3315-3315
Open Access | Times Cited: 29
Alan Chun Kit Lee, Pui Man Lau, Yiu Wa Kwan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3315-3315
Open Access | Times Cited: 29
Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer
Xiaodong Yu, Zhongbo Du, Pingyu Zhu, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 2, pp. 273-286
Closed Access | Times Cited: 4
Xiaodong Yu, Zhongbo Du, Pingyu Zhu, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 2, pp. 273-286
Closed Access | Times Cited: 4
Golgicide A induces pyroptosis of lung cancer stem cells by regulating dTGN formation via GOLPH3/MYO18A complex
Feng Zhang, S.J. Zhang, Teng Liu, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Feng Zhang, S.J. Zhang, Teng Liu, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
ITGB1/FERMT1 mechanoactivation enhances CD44 characteristic stemness in oral squamous cell carcinoma via ubiquitin-dependent CK1α degradation.
Xiang Li, Huijun Zhao, Erhui Jiang, et al.
PubMed (2025)
Closed Access
Xiang Li, Huijun Zhao, Erhui Jiang, et al.
PubMed (2025)
Closed Access
Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells
Qikai Sun, Zechuan Zhang, Yijun Lu, et al.
Hepatology (2019) Vol. 71, Iss. 6, pp. 2033-2049
Closed Access | Times Cited: 34
Qikai Sun, Zechuan Zhang, Yijun Lu, et al.
Hepatology (2019) Vol. 71, Iss. 6, pp. 2033-2049
Closed Access | Times Cited: 34
A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3—PBX1 and β-catenin—ABCG2 signaling
Chia-Hsun Fang, Yi-Te Lin, Chi‐Ming Liang, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 29
Chia-Hsun Fang, Yi-Te Lin, Chi‐Ming Liang, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 29
THBS4 silencing regulates the cancer stem cell‐like properties in prostate cancer via blocking the PI3K/Akt pathway
Yi Hou, Hai Li, Wei Huo
The Prostate (2020) Vol. 80, Iss. 10, pp. 753-763
Closed Access | Times Cited: 29
Yi Hou, Hai Li, Wei Huo
The Prostate (2020) Vol. 80, Iss. 10, pp. 753-763
Closed Access | Times Cited: 29
Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges
Juan Wang, Xiaoya Wang, Xintong Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
Juan Wang, Xiaoya Wang, Xintong Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
Andrographolide and Melatonin Synergistically Inhibit the Sox Proteins Expression in Colospheroids
Aditi Banerjee
Archives of Pharmacy & Pharmacology Research (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 3
Aditi Banerjee
Archives of Pharmacy & Pharmacology Research (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 3
Oxidative stress in normal hematopoietic stem cells and leukemia
Azin Samimi, Heibatullah Kalantari, Marzieh Zeinvand lorestani, et al.
Apmis (2018) Vol. 126, Iss. 4, pp. 284-294
Closed Access | Times Cited: 31
Azin Samimi, Heibatullah Kalantari, Marzieh Zeinvand lorestani, et al.
Apmis (2018) Vol. 126, Iss. 4, pp. 284-294
Closed Access | Times Cited: 31
Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives
Maria Giovanna Scioli, Sonia Terriaca, Elena Fiorelli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10572-10572
Open Access | Times Cited: 22
Maria Giovanna Scioli, Sonia Terriaca, Elena Fiorelli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10572-10572
Open Access | Times Cited: 22
Modulating undruggable targets to overcome cancer therapy resistance
Catherine Passirani, Anne Vessières, Giuseppe La Regina, et al.
Drug Resistance Updates (2021) Vol. 60, pp. 100788-100788
Open Access | Times Cited: 21
Catherine Passirani, Anne Vessières, Giuseppe La Regina, et al.
Drug Resistance Updates (2021) Vol. 60, pp. 100788-100788
Open Access | Times Cited: 21
Postoperative serum interleukin-6 levels correlate with survival in stage I-III colorectal cancer
Shouhan Feng, Zeshi Li, Mei Liu, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Shouhan Feng, Zeshi Li, Mei Liu, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
MicroRNAs in Body Fluids: A More Promising Biomarker for Clear Cell Renal Cell Carcinoma
Lei Shi, Mengheng Wang, Haiping Li, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 7663-7675
Open Access | Times Cited: 19
Lei Shi, Mengheng Wang, Haiping Li, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 7663-7675
Open Access | Times Cited: 19
Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG)
Chen Lyu, Lili Wang, Birgit Stadlbauer, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4200-4200
Open Access | Times Cited: 13
Chen Lyu, Lili Wang, Birgit Stadlbauer, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4200-4200
Open Access | Times Cited: 13
